FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

79580006: Adrenal hormone (substance)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
132027012 Adrenal hormone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
820645017 Adrenal hormone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
132027012 Adrenal hormone en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
132027012 Adrenal hormone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
820645017 Adrenal hormone (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
820645017 Adrenal hormone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

71 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Adrenal hormone Is a Pituitary or adrenal hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Adrenal hormone Is a Hormone true Inferred relationship Existential restriction modifier (core metadata concept)
Adrenal hormone Has disposition Adrenal hormone (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Adrenal hormone Is a Substance categorized by disposition false Inferred relationship Existential restriction modifier (core metadata concept)
Adrenal hormone Is a hormones et leurs métabolites et précurseurs false Inferred relationship Existential restriction modifier (core metadata concept)
Adrenal hormone Is a Substance with molecular messenger mechanism of action (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Budesonide 50mcg/dose The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely fluorometholone 1 milligram/1 milliliter conventional release eye suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely fluorometholone 2.5 milligram/1 milliliter conventional release eye suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone acetonide 0.055mg/inh The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Amcinonide 1 mg/mL cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone diacetate 40 mg/mL suspension for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluocinonide 500 microgram/mL cutaneous solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone acetonide 3mg injection suspension ampule 1mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Hydrocortisone 2.5% lotion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrocortisone 10 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluorometholone acetate 0.1% suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Flunisolide 0.025% solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Flunisolide 0.025mg spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Beclomethasone dipropionate 0.042% spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 44mcg/actn aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 110mcg/actn aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 220mcg/actn aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 0.05% spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 9g spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Halobetasol propionate 0.05% cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Halobetasol propionate 0.05% ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous ointment The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone dipropionate 0.5mg cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone acetonide 200mcg/spr The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Beclomethasone dipropionate 42mcg inhaler (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Clobetasol propionate 500 microgram/g cutaneous foam The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phospha 15mg/5mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone acetonide 40mg/mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fludrocortisone acetate 0.1mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Beclomethasone 84mcg (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Budesonide 0.5mg/2mL suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Beclomethasone dipropionate 42mcg/act The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone acetonide 55mcg/spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Budesonide 7g inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Methylprednisolone sodium succinate 500g powder for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Methylprednisolone acetate 40mg suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Mometasone furoate monohydrate 50mcg spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 110mcg (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone dipropionate0.5% ointment (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Flunisolide 0.025%wv solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone acetonide 100mcg/spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Beclomethasone dipropionate 84mcg/spray spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Diflorasone diacetate 0.05%wv The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Methylprednisolone sodium su 40mg powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Flurandrenolide 4mcg/sq/cm tape The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Budesonide 32micrograms aqueous nasal spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone acetonide 55mcg spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Methylprednisolone sodium su 125mg/2mL powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Methylprednisolone sodium su 40mg/mL powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone valerate 0.12% The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Flunisolide 25mcg/spray spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluocinonide 500 microgram/g cutaneous gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone valerate 0.12% aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely betamethasone 600 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone dipropionate 0.05% lotion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Methylprednisolone sodium su 125mg injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone dipropionate 0.05% gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Beclomethasone dipropionate 42mcg/spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Beclomethasone dipropionate 8.4mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone sodium phospha 3mg/mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone 0.6mg/5mL syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Beclometasone dipropionate 84 microgram/actuation nasal spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Beclomethasone dipropionate 40mcg aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Beclomethasone dipropionate 80mcg aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone acetonide 1 mg/mL cutaneous cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrocortisone 25 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Clobetasol propionate 500 microgram/g cutaneous gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Beclomethasone dipropionate 42mcg aerosol (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely clobetasol propionate 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 44mcg aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 110mcg/spray aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 110mcg aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 220mcg aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 220mcg/spray aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 44mcg/inh aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 50mcg/spray spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 125mcg/spr inhalant The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 250mcg/spr inhalant The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 50mcg/spr inhalant The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fludroxycortide 500 microgram/mL cutaneous lotion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Budesonide 200mcg/spray powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Budesonide 32mcg/spray spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Budesonide 0.25mg/2 mL suspension (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone diacetate 25mg/mL injection suspension ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone diacetate 40mg/mL injection suspension ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone hexacetonide 5mg/mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Triamcinolone hexacetonide 20mg/mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Prednisone 5mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Benzoyl peroxide + hydrocortisone 50mg/5mg lotion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone acetate + betamethasone sodium phosphate 3mg/3mg per mL injection suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone acetate + betamethasone sodium phospha 3mg/ns soluspan The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone dipropionate + clotrimazole 0.64mg/10mg cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone dipropionate + clotrimazole ns/10mg lotion (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Chloroxylenol + hydrocortisone + pramoxine hydrochloride 1mg/10mg/10mg drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Clioquinol + hydrocortisone + pramoxine hydrochloride 3%ww/1%ww/0.5%ww The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Clioquinol + hydrocortisone 3%ww/0.5%ww cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Clioquinol + hydrocortisone 3%ww/0.5%ww lotion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Clioquinol + hydrocortisone 30mg/10mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)
Fluorometholone + sulfacetamide sodium 0.1%wv/10%wv suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adrenal hormone Inferred relationship Existential restriction modifier (core metadata concept)

Start Previous Page 5 of 6 End

This concept is not in any reference sets

Back to Start